A review of the pharmacology and clinical activity of new chemotherapeutic agents in lung cancer.
Rajkumar
S V
SV
Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Adjei
A A
AA
D000470:Alkaloids / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000401:mortality; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000401:mortality; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D059004:Topoisomerase I Inhibitors; D014747:Vinblastine / Q000031:analogs & derivatives / Q000494:pharmacology; D000077235:Vinorelbine; D000093542:Gemcitabine
D000470:Alkaloids; D000970:Antineoplastic Agents; D059004:Topoisomerase I Inhibitors; D003841:Deoxycytidine; D014747:Vinblastine; D000077235:Vinorelbine; D000093542:Gemcitabine